Reactive oxygen species-responsive nanocarrier ameliorates murine colitis by intervening colonic innate and adaptive immune responses
Molecular Therapy · 2023-05 · 31 (5) · 1383-1401
DOI: 10.1016/j.ymthe.2023.02.017 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Therapy, 2023-05. Verfasst von Xiangji Yan und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary Surgery, the First Affiliated Hospital, School of Basic Medical Sciences, Xi'an Jiaotong University, Xi'an, Shaanxi 71006…. Hauptthemen laut MEDLINE: Colitis, Colitis, Ulcerative. Die Arbeit wurde bisher 78-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Ulcerative colitis (UC) is a chronic or relapsing inflammatory disease with limited therapeutic outcomes. Pterostilbene (PSB) is a polyphenol-based anti-oxidant that has received extensive interest for its intrinsic anti-inflammatory and anti-oxidative activities. This work aims to develop a reactive oxygen species (ROS)-responsive, folic acid (FA)-functionalized nanoparticle (NP) for efficient PSB delivery to treat UC. The resulting PSB@NP-FA had a nano-scaled diameter of 231 nm and a spherical shape. With ROS-responsive release and ROS-scavenging properties, PSB@NP could effectively scavenge H2O2, thereby protecting cells from H2O2-induced oxidative damage. After FA modification, the resulting PSB@NP-FA could be internalized by RAW 264.7 and Colon-26 cells efficiently and preferentially localized to the inflamed colon. In dextran sulfate sodium (DSS)-induced colitis models, PSB@NP-FA showed a prominent ROS-scavenging capacity and anti-inflammatory activity, therefore relieving murine colitis effectively. Mechanism results suggested that PSB@NP-FA ameliorated colitis by regulating dendritic cells (DCs), promoting macrophage polarization, and regulating T cell infiltration. Both innate and adaptive immunity were involved. More importantly, the combination of the PSB and dexamethasone (DEX) enhanced the therapeutic efficacy of colitis. This ROS-responsive and ROS-scavenging nanocarrier represents an alternative therapeutic approach to UC. It can also be used as an enhancer for classic anti-inflammatory drugs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hepatobiliary Surgery, the First Affiliated Hospital, School of Basic Medical Sciences, Xi'an Jiaotong University, Xi'an, Shaanxi 710061, China; Key Laboratory of Environment and Genes Related to Diseases,…
- Institute of Cardiovascular Sciences, Guangxi Academy of Medical Sciences, Nanning, Guangxi 530021, China; Center for Systemic Inflammation Research (CSIR), Youjiang Medical University for Nationalities, Baise, Guangxi…
- Department of Pathogenic Microbiology and Immunology, School of Basic Medical Sciences, Xi'an Jiaotong University, Xi'an, Shaanxi 710061, China; Xi'an Key Laboratory of Immune Related Diseases, Xi'an, Shannxi 710061, Ch…
- Department of Hepatobiliary Surgery, the First Affiliated Hospital, School of Basic Medical Sciences, Xi'an Jiaotong University, Xi'an, Shaanxi 710061, China. Electronic address: tks0912@foxmail.com.
- Laboratory of Tumor Molecular Diagnosis and Individualized Medicine of Zhejiang Province, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang 310014, China;…
Zitieren
APA
Yan, X., Meng, L., Zhang, X., Deng, Z., Gao, B., Zhang, Y., Yang, M., Ma, Y., Zhang, Y., Tu, K., Zhang, M., & Xu, Q. (2023). Reactive oxygen species-responsive nanocarrier ameliorates murine colitis by intervening colonic innate and adaptive immune responses. Molecular Therapy, 31(5), 1383-1401. https://doi.org/10.1016/j.ymthe.2023.02.017
Vancouver
Yan X, Meng L, Zhang X, Deng Z, Gao B, Zhang Y, et al. Reactive oxygen species-responsive nanocarrier ameliorates murine colitis by intervening colonic innate and adaptive immune responses. Molecular Therapy. 2023;31(5):1383-1401. doi:10.1016/j.ymthe.2023.02.017
BibTeX
@article{Yan2023,
author = {Yan, Xiangji and Meng, Lingzhang and Zhang, Xingzhe and Deng, Zhichao and Gao, Bowen and Zhang, Yujie and Yang, Mei and Ma, Yana and Zhang, Yuanyuan and Tu, Kangsheng and Zhang, Mingzhen and Xu, Qiuran},
title = {Reactive oxygen species-responsive nanocarrier ameliorates murine colitis by intervening colonic innate and adaptive immune responses},
journal = {Molecular Therapy},
year = {2023},
volume = {31},
number = {5},
pages = {1383--1401},
doi = {10.1016/j.ymthe.2023.02.017}
}
EUVIMED